• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION 213, LLC 0113 UNKNOWN CHLORAPREP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION 213, LLC 0113 UNKNOWN CHLORAPREP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fungal Infection (2419)
Event Date 02/21/2022
Event Type  Injury  
Event Description
Material#: unknown.Batch#: unknown.It was reported of an other event.Verbatim: reported issues: purpose: to highlight the relevance of the study of microbiological corneal samples in the treatment and typing of atypical corneal ulcers.Epicoccum nigrum is a fungus belonging to the yeast category.It is found in cereal and fruit crops.It is used in the medical and agricultural industry as an antimicrobial.Methods: we present a descriptive study (case report).We have performed a clinical, imaging and microbiological follow up of a patient with an atypical corneal ulcer in the right eye.A corneal scraping was performed for microbiological analysis, resulting in the presence of a filamentous fungus.The sample was sent to a specialized laboratory in (b)(6) confirming the presence of epicoccum nigrum in the corneal tissue.Results: the patient presented with decreased visual acuity and pain in the right eye unrelated to trauma, nor is she a contact lens wearer.The patient lives in a rural area and works as a fruit picker.Examination showed an infiltrated corneal ulcer with significant epithelial defect and stromal edema.The best corrected visual acuity was 0.05.A sample was taken for culture and treatment with voriconazole and chlorhexidine was started.The culture confirms the existence of filamentous fungus, and treatment with topical natamycin was started.The culture was analyzed in a laboratory outside our center and was positive for epicoccum nigrum.After 10 months with no activity observed, penetrating keratoplasty was performed on the right eye and the patient currently has a better corrected visual acuity of 0.3.Conclusions: this is the first clinical case in which the presence of epicoccum nigrum is detected in corneal tissue.There are no previous cases documented in scientific literature.Due to the difficulty in confirming its presence in cultures in non-specialized centers, we could suppose that perhaps its prevalence in corneal ulcers was higher than what is known.
 
Manufacturer Narrative
(b)(6).Initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN CHLORAPREP
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION 213, LLC 0113
1550 northwestern dr
el paso TX 79912
Manufacturer (Section G)
CAREFUSION, INC
75 n. fairview drive
vernon hills IL 60061
Manufacturer Contact
anna wehrheim
75 n. fairview drive
vernon hills, IL 60061
8015652341
MDR Report Key13702469
MDR Text Key291615708
Report Number3004932373-2022-00069
Device Sequence Number1
Product Code KXG
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-